Search Results

You are looking at 61 - 70 of 624 items for :

  • T regulatory cell x
Clear All
Open access

Ewelina Wawryk-Gawda and Beata Wojcik

erythematosus. Arthritis Rheum 62(8):2467-75, 2010. doi: 10.1002/art.27548. 39. Sun Y., Zhang F.S., Zhang Z.Y.: Immunoregulatory effect of bone marrow mesenchymal stem cells on regulatory T cells in patients with systemic lupus erythematosis. Zhonghua Nei Ke Za Zhi 46(12):1018-21, 2007. 40. Tyndall A.: Application of autologous stem cell transplantation in various adult and pediatric rheumatic diseases. Pediatr Res 71(4 Pt 2):433-8, 2012. doi: 10.1038/pr.2011.66. 41. van Velthoven C.T., Gonzalez F., Vexler Z.S., Ferriero D

Open access

Paramee Thongsuksai, Kowit Pruegsanusak and Pleumjit Boonyaphiphat

. Regulators of cell death. Trends Genet. 1995; 11:101-5. 5. Hall PA, Meek D, Lane DP. p53-integrating the complexity. J Pathol. 1996; 180:1-5. 6. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994; 9:1799-805. 7. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993; 366:704-7. 8. Mork J, Lie AK

Open access

Iman Fahmy, Azza Amer and Nagwa El-Ghaffar

;2:78-83. Rich R. Exfoliation syndrome: The most common cause of open angle glaucoma. J Glaucoma. 1991;2:176-178. Raivich G, Jones LL, K Ioss CU, et al. Immune nervous system. T-Lymphocytes invade the axotomized mouse facial motor nucleus. J Neuro Sci. 1998;18:5804-5816. Streilein JW. Immune-regulatory mechanisms of the eye. Prog Retin Eye Res. 1999;18(3):357-370. Amadi-Obi A, Yu CR, Liu X, et al. TH17 Cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1

Open access

Xiao Feng Zhu, Wan Hui Cai, Jin Hee Jung and Yuan Hu Xuan

chindelasch D, T himm O, U dvardi MK, and S titt M. 2004. Genome-wide reprogramming of primary and secondary metabolism, protein synthesis, cellular growth processes, and the regulatory infrastructure of Arabidopsis in response to nitrogen. Plant Physiology 136: 2483–2499. S onoda Y, I keda A, S aiki S, von W iren N, Y amaya T, and Y amaguchi J. 2003. Distinct expression and function of three ammonium transporter genes (OsAMT1;1-1;3) in rice. Plant Cell Physiology 44: 726–734. T abuchi M, A biko T, and Y amaya T. 2007. Assimilation of

Open access

Milan Marković, Sergej Tomić, Jelena Djokić and Miodrag Čolić

Immunol 2005; 20: 310-6. 4. Gazivoda D, Džopalić T, Božić B et al. Production of proinflammatory and immunoregulatory cytokines by inflammatory cells from periapical lesions in culture. J Oral Pathol Med 2009; 38: 605-11. 5. Fukada SY, Silva TA, Garlet GP et al. Factors involved in the T helper type 1 and type 2 cell commitment and osteoclast regulation in inflammatory apical diseases. Oral Microbiol Immunol 2009; 24: 25-31. http

Open access

Claudia Salvadori, Tanja Svara, Guido Rocchigiani, Francesca Millanta, Darja Pavlin, Maja Cemazar, Ursa Lampreht Tratar, Gregor Sersa, Natasa Tozon and Alessandro Poli

. Successful treatment of equine sarcoids with cisplatin electrochemotherapy: a retrospective study of 48 cases Equine Vet J 2012 44 214 20 10.1111/j.2042-3306.2011.00425.x 22 Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune provolege and predicts reduced survival. Nat Med 2004; 10 : 942-9. 10.1038/nm1093 Curiel TJ Coukos G Zou L Alvarez X Cheng P Mottram P Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune provolege and predicts

Open access

Gordana D. Radosavljevic, Jelena Pantic, Ivan Jovanovic, Miodrag L. Lukic and Nebojsa Arsenijevic

Communications, 460, 302-307. 89. Markowska AI, Liu FT, Panjwani N. (2010). Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response. J Exp Med, 207, 1981–1993. 90. Lindau D, Gielen P, Kroesen M, Wesseling P, Adema GJ. (2013). The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology, 138, 105–115. 91. Motz GT, Coukos G. (2013). Deciphering and reversing tumor immune suppression. Immunity, 39, 61–73. 92. Demotte N, Wieers G, VanDer Smissen P, Moser M

Open access

Sylwia Terpiłowska, Dorota Siwicka-Gieroba and Andrzej Krzysztof Siwicki

G.L.: In vitro setting of dose-effect relationships of 32 metal compounds in the Balb/3T3 cell line, as a basis for predicting their carcinogenic potential. ATLA 2002, 30, 209–221. 18. Meek B., Doull J.: Pragmatic challenges for the vision of toxicity testing in the 21 st century in a regulatory context: another Ames test? or a new edition of “the Red Book”?. Toxicol Sci 2009, 108, 19–21. 19. Minaeva O.V., Brodovskaya E.P., Pyataev M.A., Gerasimov M.V., Zharkov M.N., Yurlov I.A., Kulikov O.A., Kotlyarov A.A., Balykova L.A., Kokorev A.V., Zaborovskiy

Open access

Sabina Galiniak, Izabela Krawczyk-Merć and Agnieszka Pedrycz

cell lines derived from human blastocysts. Science 1998; 282(5391):1145-7. 8. Tabei I, Hashimoto H, Ishiwata I, Tokieda Y, Tachibana T, Akahori M et al. New approach for the establishment of an hepatocyte cell line derived from rat early embryonic stem cells. Hum Cell 2003; 16(1):39-46. 9. Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M et al. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 2000; 6(2):88-95. 10. Pera MF, Tam PP. Extrinsic regulation of

Open access

Sylwia Tobólska, Sylwia Terpiłowska, Jerzy Jaroszewski and Andrzej Krzysztof Siwicki

toxicological effects in vitro of this compound have not been deeply studied. Inosine pranobex potentiates T lymphocyte and phagocytic cell function. Moreover, it enhances mitogen-dependent and antigen-dependent lymphocyte DNA synthesis. It induces the gene expression of phenotypic markers of differentiation on immature precursor T cells, boosts helper or suppressor T cell functions, and increases the production of lymphotoxin ( 2 ). The drug has potential therapeutic use in animals. Immunotherapy may be especially beneficial in animals infected with viral strains